β3 Agonists Show No Dementia Advantage Over Anticholinergics in OAB – The American Journal of Managed Care
β3 Agonists Show No Dementia Advantage Over Anticholinergics in OAB The American Journal of Managed Care
Discussion disabled.
Category: Dementia